Table 2. Mutated pathways and functions in each group of patients.
Good prognosis | ||||
---|---|---|---|---|
FUNCTION | score good | score poor | dif.score | p-val |
APOPTOSIS (KEGG) | 0.903 | 0.432 | −0.472 | 0.001 |
SMALL CELL LUNG CANCER (KEGG) | 0.828 | 0.452 | −0.376 | 0.012 |
DILATED CARDIOMYOPATHY (KEGG) | 0.837 | 0.540 | −0.297 | 0.039 |
VEGF SIGNALING PATHWAY (KEGG) | 0.817 | 0.538 | −0.279 | 0.037 |
CELL CYCLE (KEGG) | 0.621 | 0.365 | −0.256 | 0.020 |
LIPID KINASE ACTIVITY (GO) | 1.863 | 0.487 | −1.376 | 0.002 |
INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY (GO) | 1.242 | 0.325 | −0.917 | 0.002 |
Poor prognosis | ||||
FUNCTION | score good | score poor | dif.score | p-val |
NUCLEOTIDE EXCISION REPAIR (KEGG) | 0.113 | 0.398 | 0.285 | 0.050 |
TIGHT JUNCTION (KEGG) | 0.389 | 0.654 | 0.265 | 0.019 |
DNA POLYMERASE ACTIVITY (GO) | 0.000 | 0.812 | 0.812 | 0.008 |
DNA DIRECTED DNA POLYMERASE ACTIVITY (GO) | 0.000 | 0.626 | 0.626 | 0.008 |